Advertisement
PAVM vs SYK
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PAVM is a Buy and SYK is a Hold.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
PAVM’s FA Score shows that 0 FA rating(s) are green whileSYK’s FA Score has 2 green FA rating(s).
- PAVM’s FA Score: 0 green, 5 red.
- SYK’s FA Score: 2 green, 3 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
PAVM’s TA Score shows that 5 TA indicator(s) are bullish while SYK’s TA Score has 7 bullish TA indicator(s).
- PAVM’s TA Score: 5 bullish, 4 bearish.
- SYK’s TA Score: 7 bullish, 4 bearish.
Price Growth
PAVM (@Medical/Nursing Services) experienced а -12.16% price change this week, while SYK (@Medical/Nursing Services) price change was -1.70% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +0.72%. For the same industry, the average monthly price growth was +2.19%, and the average quarterly price growth was +8.42%.
Reported Earning Dates
SYK is expected to report earnings on Feb 03, 2026.
Industries' Descriptions
@Medical/Nursing Services (+0.72% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
| PAVM | SYK | PAVM / SYK | |
| Capitalization | 8.81M | 140B | 0% |
| EBITDA | 68.6M | 5.76B | 1% |
| Gain YTD | -49.227 | 2.324 | -2,118% |
| P/E Ratio | 0.09 | 48.09 | 0% |
| Revenue | 1.02M | 23.8B | 0% |
| Total Cash | 4M | N/A | - |
| Total Debt | 9.31M | 16.6B | 0% |
PAVM | SYK | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 60 | 16 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 96 Overvalued | 50 Fair valued | |
PROFIT vs RISK RATING 1..100 | 100 | 23 | |
SMR RATING 1..100 | 100 | 56 | |
PRICE GROWTH RATING 1..100 | 89 | 56 | |
P/E GROWTH RATING 1..100 | 100 | 26 | |
SEASONALITY SCORE 1..100 | n/a | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
SYK's Valuation (50) in the Medical Specialties industry is somewhat better than the same rating for PAVM (96). This means that SYK’s stock grew somewhat faster than PAVM’s over the last 12 months.
SYK's Profit vs Risk Rating (23) in the Medical Specialties industry is significantly better than the same rating for PAVM (100). This means that SYK’s stock grew significantly faster than PAVM’s over the last 12 months.
SYK's SMR Rating (56) in the Medical Specialties industry is somewhat better than the same rating for PAVM (100). This means that SYK’s stock grew somewhat faster than PAVM’s over the last 12 months.
SYK's Price Growth Rating (56) in the Medical Specialties industry is somewhat better than the same rating for PAVM (89). This means that SYK’s stock grew somewhat faster than PAVM’s over the last 12 months.
SYK's P/E Growth Rating (26) in the Medical Specialties industry is significantly better than the same rating for PAVM (100). This means that SYK’s stock grew significantly faster than PAVM’s over the last 12 months.
| PAVM | SYK | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 84% | 2 days ago 62% |
| Stochastic ODDS (%) | 2 days ago 89% | 2 days ago 62% |
| Momentum ODDS (%) | 2 days ago 86% | 2 days ago 55% |
| MACD ODDS (%) | 2 days ago 83% | 2 days ago 57% |
| TrendWeek ODDS (%) | 2 days ago 89% | 2 days ago 52% |
| TrendMonth ODDS (%) | 2 days ago 90% | 2 days ago 46% |
| Advances ODDS (%) | 7 days ago 85% | 10 days ago 54% |
| Declines ODDS (%) | 2 days ago 90% | 2 days ago 53% |
| BollingerBands ODDS (%) | 2 days ago 87% | 2 days ago 70% |
| Aroon ODDS (%) | 2 days ago 90% | 2 days ago 63% |
Advertisement
PAVM and
Correlation & Price change
A.I.dvisor tells us that PAVM and GMED have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PAVM and GMED's prices will move in lockstep.
| Ticker / NAME | Correlation To PAVM | 1D Price Change % | ||
|---|---|---|---|---|
| PAVM | 100% | -3.22% | ||
| GMED - PAVM | 26% Poorly correlated | -1.44% | ||
| CVRX - PAVM | 25% Poorly correlated | +3.35% | ||
| RVTY - PAVM | 25% Poorly correlated | +0.52% | ||
| CSTL - PAVM | 24% Poorly correlated | +0.79% | ||
| SYK - PAVM | 23% Poorly correlated | -0.20% | ||
More | ||||
SYK and
Correlation & Price change
A.I.dvisor indicates that over the last year, SYK has been loosely correlated with BSX. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is some statistical probability that if SYK jumps, then BSX could also see price increases.